FYN抗体

+ +

•  

   

     Red: Control Antigen (100ng); Purple: Antigen (10ng); Green: Antigen (50ng); Blue: Antigen (100ng);    

  
  

•  

   

     Immunofluorescence analysis of U251 cells using FYN mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor-555 phalloidin.    

  
  

•  

   

     Flow cytometric analysis of Hela cells using FYN mouse mAb (green) and negative control (purple).    

  
  

•  

   

     Immunohistochemical analysis of paraffin-embedded human breast cancer tissues (left) and brain tissues (right) using FYN mouse mAb with DAB staining.    

  
  

The FYN antibody is a crucial tool in studying FYN, a non-receptor tyrosine kinase belonging to the SRC family. FYN plays diverse roles in cellular signaling, including T-cell receptor activation, integrin signaling, and neuronal development. It is particularly important in brain function, influencing processes like myelination, synaptic plasticity, and memory formation. Aberrant FYN activity has been linked to cancers, Alzheimer’s disease, multiple sclerosis, and autoimmune disorders, making it a key research target.

FYN antibodies are designed to detect specific isoforms (e.g., neuronal p59FYN and ubiquitous p62FYN) or phosphorylation states (e.g., Y420 activation site) of the protein. They are widely used in techniques like Western blotting, immunoprecipitation, and immunohistochemistry to map FYN expression, localization, and activation patterns in tissues or cultured cells. Some antibodies distinguish between FYN and related kinases (e.g., SRC, YES) to ensure assay specificity.

These antibodies have advanced both basic research and translational studies. In neuroscience, they help explore FYN's interaction with amyloid-beta or tau in Alzheimer’s models. In oncology, they assess FYN's role in tumor metastasis and drug resistance. Commercially available FYN antibodies are typically validated across species (human, mouse, rat) and sample types, though variability in sensitivity remains a consideration. Recent efforts focus on developing phospho-specific antibodies to dissect FYN signaling dynamics, aiding drug discovery for FYN-associated diseases.